Cloopen Group Holding Limited (NYSE: RAAS), Athira Pharma Inc. (NASDAQ: ATHA), and AcelRx Pharmaceuticals Inc. (NASDAQ: ACRX) are under investigation for potential federal securities laws violation. AcelRx’s lead candidate DSUVIA AcelRx develops acute pain treatment therapies, and its lead candidate DSUVIA, has FDA approval for acute pain management. On February […]
Tag: NASDAQ: ATHA
Athira Pharma Inc (NASDAQ: ATHA) Tanks on Account of the CEO Temporary Leave
Athira Pharma Inc (NASDAQ: ATHA) exited the market at $11.15 in its last trading session. It was down 39%. The average yearly range of this stock is $9.70 – $34.79, and at the moment, the stock is closer to its all-time low. The market capitalization of this company is 415.03M […]